Advanced Biomed secures up to $25M equity purchase agreement with Helena Global

Advanced Biomed Inc.

Company enters purchase agreement with HELENA GLOBAL for up to $25M of common stock.
Company may sell shares at its discretion; purchase price equals lowest intraday price during a 3-day pricing period.
Maximum advance capped at the lesser of 25% of 5-day average daily value traded or $2M per draw.
Investor ownership limitation set at 4.99% of outstanding common stock.
Agreement dated June 6, 2025; shares to be sold in reliance on Section 4(a)(2) exemption.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.